1. Intramuscular administration of 15(S)-15-methyl-prostaglandin E2-methyl ester for induction of abortion
- Author
-
David A. Grimes, Linda G. Staurovsky, Thampu Kumarasamy, William E. Brenner, and James R. Dingfelder
- Subjects
Adult ,Diarrhea ,Time Factors ,Adolescent ,Fever ,Side effect ,Vomiting ,Pain ,Abortion ,Injections, Intramuscular ,Pregnancy ,medicine ,Humans ,Endocrine system ,Prostaglandin E2 ,Abortifacient Agents ,business.industry ,Shivering ,Obstetrics and Gynecology ,Abortion, Induced ,Esters ,medicine.disease ,Blood Cell Count ,Hypertonic saline ,Pregnancy Trimester, First ,Oxytocin ,Pregnancy Trimester, Second ,Anesthesia ,Prostaglandins ,Female ,medicine.symptom ,business ,medicine.drug - Abstract
An intramuscular dose schedule of 15(S)-15-methyl-prostaglandin E2-methyl ester (15-(S)-ME PGE2) was evaluated for its application as a midtrimester abortifacient route. 20 healthy gravidas aged 18-42 years and 8-22 menstrual weeks of gestation were aborted in the Clinical Research Unit of the University of North Carolina Memorial Hospital. The subjects were given 5 mcg of the PGE2 methyl ester every 4 hours. 85% (17/20) aborted within 48 hours, 65% (13/20) of these within 24 hours. Mean induction-abortion interval was 21 hours. Trials were defined as complete in 55%, incomplete in 30%, and failure in 15%. Shivering, fever, pain, vomiting, and diarrhea were the most common side effects. The transient shivering occurred in 13 (65%) of the subjects within 20 minutes of the first dose. Fever usually started after shivering, and both resolved spontaneously. 2 patients had estimated blood loss exceeding 500 ml, but they were not given transfusions. No clinically significant changes occurred in mean hemotocrit, platelet count, serum creatinine, bilirubin, alkaline phosphatase, electrolytes, serum glutamic oxalacetic transaminase, and serum glutamic pyruvic transaminase. Mean blood cell and neutrophil counts increased, but neither increase was statistically significant.
- Published
- 1974